Eptifibatide Injection
Product Images NDC 70436-026

Eptifibatide is an injection medication, which contains 2mg of eplifibalide and 5.25 mg citric acid, and is used for intravenous use only. Its pH of 5.35, which has been adjusted using sodium hydroxide, is stable for up to two months if stored at 2-8°C or 36-46°F. After this, it may be kept for a further two months if stored below 25°C or 77°F, but must be discarded if it remains unused. This medication is available in a single-dose vial with a dosage based on the patient's weight, as indicated by the accompanying package insert. This product is manufactured in China by Hainan Poly Pharm, Co. Ltd, and distributed by Slate Run Pharmaceuticals, LLC, Columbus, Ohio.*

Eptifibatide Injection is a medication administered intravenously for preventing complications associated with certain heart and blood vessel conditions. It contains 0.75 mg eptifibatide and 5.25 mg citric acid in water for an injection with pH adjusted with sodium hydroxide. It comes in a 75mg/100ml single-dose vial for weight-adjusted bolus dosing, which should be stored at a cool temperature between 2 to 8°C (36° to 46°F) until transfer to 25°C (77°F; USP Controlled Room Temperature) for up to two months. Protect the medicine from light until administration and discard it if not used within 2 months. Please refer to the accompanying package insert for the correct dosage. The medicine is manufactured by Hainan Poly Pham. Co., Ltd. in China and distributed by Slate Run Pharmaceuticals, LLC in Columbus, Ohio. The code for the medication is NDC 70436-027-80.*

The text is describing a chart showing the percentage of patients with events over time for two treatments: Eptifibatide and Placebo. The x-axis shows time in days and the y-axis shows the percentage of patients with events. The percentages increase for both treatments over time, but the percentage is lower for Eptifibatide. No further information is available.*

This is a description of a medication with NDC code 70436-027-80 called Eptifibatide Injection. Each mL contains 0.75 mg eptifibatide and 5.25 mg citric acid in water for injection. The pH is adjusted with sodium hydroxide to 5.35. The medication is stored refrigerated at 2° to 8°C and may be transferred to 25°C for up to 2 months. It should be protected from light until administration and must be discarded if not used within 2 months of transfer. The dosage information can be found in the accompanying package insert. This medication is manufactured in China and distributed in the US by Slate Run Phamaceuticals, LLC, Columbus, Ohio 43215.*

Eptifibatide is an injection medication used for intravenous use only. Each milliliter contains 2 mg of eptifibalide, 5.25 mg of citric acid in water for injection, and the pH has been adjusted with sodium hydroxide to pH 5.35. The medication is typically administered with a weight-adjusted bolus dosage, and appropriate instructions should be followed as per the package insert. The medication should be stored refrigerated at 2° to 8°C (36° to 46°F) and can be transferred to 25°C (77°F) for up to 2 months. The medication must be discarded if not used within 2 months of transfer. The product is manufactured by Hainan Poly Pharm, Co, Lid, in China and distributed by Slate Run Pharmaceuticals, LLC, in Columbus, Ohio.*